chr11-32392013-T-C

Variant summary

Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PM2PM5PP3PP5_Moderate

The NM_024426.6(WT1):​c.1406A>G​(p.Asp469Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D469N) has been classified as Pathogenic.

Frequency

Genomes: not found (cov: 32)

Consequence

WT1
NM_024426.6 missense

Scores

6
4
6

Clinical Significance

Likely pathogenic criteria provided, single submitter P:2

Conservation

PhyloP100: 7.99
Variant links:
Genes affected
WT1 (HGNC:12796): (WT1 transcription factor) This gene encodes a transcription factor that contains four zinc-finger motifs at the C-terminus and a proline/glutamine-rich DNA-binding domain at the N-terminus. It has an essential role in the normal development of the urogenital system, and it is mutated in a small subset of patients with Wilms tumor. This gene exhibits complex tissue-specific and polymorphic imprinting pattern, with biallelic, and monoallelic expression from the maternal and paternal alleles in different tissues. Multiple transcript variants have been described. In several variants, there is evidence for the use of a non-AUG (CUG) translation initiation codon upstream of, and in-frame with the first AUG. Authors of PMID:7926762 also provide evidence that WT1 mRNA undergoes RNA editing in human and rat, and that this process is tissue-restricted and developmentally regulated. [provided by RefSeq, Mar 2015]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_pathogenic. Variant got 7 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chr11-32392014-C-T is described in Lovd as [Pathogenic].
PP3
MetaRNN computational evidence supports a deleterious effect, 0.768
PP5
Variant 11-32392013-T-C is Pathogenic according to our data. Variant chr11-32392013-T-C is described in ClinVar as [Likely_pathogenic]. Clinvar id is 3489.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr11-32392013-T-C is described in Lovd as [Pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
WT1NM_024426.6 linkuse as main transcriptc.1406A>G p.Asp469Gly missense_variant 9/10 ENST00000452863.10 NP_077744.4

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
WT1ENST00000452863.10 linkuse as main transcriptc.1406A>G p.Asp469Gly missense_variant 9/101 NM_024426.6 ENSP00000415516 P19544-7

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
31
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Likely pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

11p partial monosomy syndrome;C0950121:Drash syndrome;C0950122:Frasier syndrome;CN033288:Wilms tumor 1 Pathogenic:1
Likely pathogenic, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpMay 28, 2017Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. A different missense substitution at this codon (p.Asp464Asn) has been determined to be pathogenic (PMID: 8810912, 5665984, 1655284, 20442690, 22876585, 24379226). This suggests that the aspartic acid residue is critical for WT1 protein function and that other missense substitutions at this position may also be pathogenic. This variant has been reported in two individuals affected with WT1-related conditions (PMID: 1655284, 24402088), and was found to be de novo in one of them (PMID: 1655284). This variant is also known as p.Asp396Gly in the literature. ClinVar contains an entry for this variant (Variation ID: 3489). This variant is not present in population databases (ExAC no frequency). This sequence change replaces aspartic acid with glycine at codon 464 of the WT1 protein (p.Asp464Gly). The aspartic acid residue is highly conserved and there is a moderate physicochemical difference between aspartic acid and glycine. -
Drash syndrome Pathogenic:1
Pathogenic, no assertion criteria providedliterature onlyOMIMOct 18, 1991- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.30
D
BayesDel_noAF
Pathogenic
0.19
CADD
Pathogenic
29
DANN
Uncertain
1.0
Eigen
Benign
0.14
Eigen_PC
Uncertain
0.35
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.89
D;.;D;.;.;.;.;.
M_CAP
Benign
0.040
D
MetaRNN
Pathogenic
0.77
D;D;D;D;D;D;D;D
MetaSVM
Benign
-0.85
T
MutationTaster
Benign
1.0
A;A
PrimateAI
Pathogenic
0.94
D
PROVEAN
Pathogenic
-6.2
D;D;D;D;D;.;.;.
REVEL
Uncertain
0.44
Sift
Benign
0.071
T;D;D;D;D;.;.;.
Sift4G
Benign
0.12
T;T;T;T;T;.;.;.
Polyphen
0.093
B;.;.;.;.;.;.;.
Vest4
0.91
MVP
0.59
ClinPred
0.99
D
GERP RS
6.0
gMVP
0.94

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs121907902; hg19: chr11-32413559; COSMIC: COSV60070732; COSMIC: COSV60070732; API